# 21Shares XRP ETF: financial statements, quarterly

TOXR · CBOE · CIK 2028835 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/toxr.md) · [Financials](/companies/toxr/financials.md) · [Filings](/companies/toxr/filings.md) · [Insiders](/companies/toxr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/toxr/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [0.0](/filings/0001213900-26-055788.md) | [15.8](/filings/0001213900-26-087823.md) | [54.7](/filings/0001213900-26-007699.md) | [(107) d](/filings/0001213900-26-036689.md) | [(52.3)](/filings/0001213900-26-055788.md) | [(32.9)](/filings/0001213900-26-087823.md) |

- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [210](/filings/0001213900-26-036689.md) | not reported | not reported | [280](/filings/0001213900-26-007699.md) | [248](/filings/0001213900-26-087823.md) | [142](/filings/0001213900-26-055788.md) | [113](/filings/0001213900-26-087823.md) |
| Total liabilities | $m | [0.2](/filings/0001213900-26-036689.md) | not reported | not reported | [0.1](/filings/0001213900-26-007699.md) | [0.0](/filings/0001213900-26-087823.md) | [0.0](/filings/0001213900-26-055788.md) | [0.0](/filings/0001213900-26-087823.md) |
| Shareholders' equity | $m | [209](/filings/0001213900-26-087823.md) | [209](/filings/0001213900-26-087823.md) | [225](/filings/0001213900-26-087823.md) | [280](/filings/0001213900-26-007699.md) | [248](/filings/0001213900-26-087823.md) | [142](/filings/0001213900-26-087823.md) | [113](/filings/0001213900-26-087823.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

Shares outstanding: 11,120,000 at 2026-08-07, from the cover of the [10-Q filed 2026-08-11](/filings/0001213900-26-087823.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.